Skip to main content

Table 1 Clinical and biochemical characteristics of RDN patients and DC

From: The cholinergic anti-inflammatory pathway in resistant hypertension treated with renal denervation

 RDN n = 10DC n = 4P values
Sex, female %2825n.s.
Age, years61.5 (47.4–71.3)66.5 (58.7–75.7)n.s.
P-hsCRP mg/ml2.5 (0.5–7.8)2.5 (1.9–4.7)n.s.
B-Hb g/L139.5 (131.6–157.6)134.5 (127.9–139)n.s.
B-WBC ×  109/L7.6 (6.6–11.9)5.6 (5.0–8.9)n.s.
B-Neutrofils × 109/L4.4 (2.6–6.6)3.0 (2.4–5.0n.s.
B-Lymphocytes × 109/L2.7 (1.5–3.4)2.0 (1.4–3.0)n.s.
B-Monocytes × 109/L0,7 (0.5–1.0)0.6 (0.4–0.8)n.s.
P-Creatinine μmol/L96.5 (79.4–156.7)83.5 (65.6–144.1)n.s.
Systolic blood pressure, mmHg, mean180148n.a.
Diastolic blood pressure, mmHg, mean10075n.a.
Anti-hypertensive medication, mean43n.a.
Diuretics %9025n.a.
ACE- inhibitor %8075n.a.
ARB %4025n.a.
Ca- channels blocker %9025n.a.
Beta-blocker %10075n.a.
Alfa- blocker %100n.a.
  1. Data are expressed as median, (10–90) percentiles and percentage. References: high sensitive C reactive protein (hsCRP) < 3 mg/L, B-Hemoglobin (Hb) 117–153 g/L (female), 134–170 g/L (male), B-White Blood cell count (WBC) 3.5–8.8 × 109/L, B-Neutrophils 1.6–5.9 × 109/L, B-Monocytes 0.1–1.0 × 109/L, B-Lymphocytes 1.0–4.0 × 109/L. P-Creatinine < 90 μmol/L (female), < 100 μmol/L (male)